Okamoto, H., Dirks, N. L., Rosario, M., Hori, T., & Hibi, T. (2021). Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease. Intest Res.
Citação norma ChicagoOkamoto, Hiroyuki, Nathanael L. Dirks, Maria Rosario, Tetsuharu Hori, and Toshifumi Hibi. "Population Pharmacokinetics of Vedolizumab in Asian and Non-Asian Patients With Ulcerative Colitis and Crohn’s Disease." Intest Res 2021.
MLA citiranjeOkamoto, Hiroyuki, et al. "Population Pharmacokinetics of Vedolizumab in Asian and Non-Asian Patients With Ulcerative Colitis and Crohn’s Disease." Intest Res 2021.
Opozorilo: Ti citati niso vedno 100% točni.